Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
1.420
-0.040 (-2.74%)
At close: Feb 21, 2025, 4:00 PM
1.490
+0.070 (4.93%)
After-hours: Feb 21, 2025, 4:27 PM EST
Fractyl Health Employees
Fractyl Health had 102 employees as of December 31, 2023. The number of employees increased by 19 or 22.89% compared to the previous year.
Employees
102
Change
19
Growth
22.89%
Revenue / Employee
$951
Profits / Employee
-$676,186
Market Cap
68.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 102 | 19 | 22.89% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
GUTS News
- 22 days ago - Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025 - GlobeNewsWire
- 2 months ago - Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - GlobeNewsWire
- 2 months ago - Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - GlobeNewsWire
- 3 months ago - Fractyl Health to Participate in the Upcoming December Conferences - GlobeNewsWire
- 3 months ago - Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024 - GlobeNewsWire
- 4 months ago - Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewsWire